In the wake of the Democratic triumph in the recent midterms, global markets have responded with a palpable sense of optimism, reflecting a complex interplay between geopolitical tensions and sector-specific dynamics. The Dow Jones Industrial Average surged by over 3%, while the S&P 500 and Nasdaq rose by 1.6% and 1.4%, respectively, signaling investor confidence in a more stable political landscape. This rally, however, is not merely a reaction to electoral outcomes but a nuanced response to the broader macroeconomic environment, particularly the escalating tensions between the US and Iran and the persistent inflationary pressures. The Democratic victory is perceived as a potential harbinger of a more measured approach to artificial intelligence (AI) regulation, which has been a significant driver of market volatility. Investors are betting on a slowdown in AI-related expenditures, particularly in the data center sector, as Democrats are expected to impose stricter regulatory frameworks. This anticipated regulatory shift is seen as a double-edged sword; while it may temper the frenetic pace of AI development, it could also mitigate the risks associated with unchecked AI expansion, thereby stabilizing the market in the long term. The energy sector, meanwhile, is bracing for a recalibration of policies, especially concerning the ongoing conflict with Iran. The Democratic control of Congress is likely to exert pressure on the Trump administration to seek a resolution to the war, which could lead to a reduction in oil prices. Brent crude futures, for instance, have already seen a significant drop, reflecting market expectations of a de-escalation in tensions. This potential easing of geopolitical strife is a critical factor in the current market optimism, as it promises to alleviate some of the inflationary pressures that have been exacerbated by volatile energy prices. Corporate developments further underscore the market's cautious optimism. CVS Health's decision to spin off its retail pharmacy business into a new entity, CVS Pharmacy, marks a significant restructuring in the healthcare sector. This move, while initially met with a sharp decline in CVS shares, is indicative of broader trends in the industry, where companies are seeking to adapt to an increasingly challenging retail pharmacy environment. The market's reaction to this development highlights the ongoing scrutiny of corporate strategies in response to macroeconomic pressures. In the semiconductor sector, the anticipated regulatory changes and the potential slowdown in AI investments could lead to a realignment of priorities. Companies may shift their focus from aggressive expansion to optimizing existing operations, which could stabilize the sector and provide a more sustainable growth trajectory. The interplay between these macroeconomic factors and corporate strategies paints a complex picture of the current market landscape. While the Democratic victory has injected a sense of optimism, the underlying challenges posed by geopolitical tensions and inflationary pressures remain. Investors are navigating this intricate environment with a cautious optimism, betting on a more stable and regulated market that balances growth with sustainability. In conclusion, the market's response to the Democratic triumph is a reflection of a broader recalibration of expectations in the face of geopolitical and economic uncertainties. The anticipated regulatory changes, particularly in the AI and energy sectors, coupled with strategic corporate developments, are shaping a market environment that is cautiously optimistic yet acutely aware of the challenges that lie ahead. As the dust settles on the midterms, the focus will shift to how these dynamics unfold in the coming months, with investors closely monitoring the interplay between policy decisions and corporate strategies in shaping the future market trajectory.
Companies Reporting Earnings Today
| Symbol | Price | Change | MarketCap |
|---|---|---|---|
| TM | 199.4600 | 3.35% | 236197464305 |
| COP | 136.9400 | -5.17% | 164511499600 |
| SONY | 25.9500 | 2.21% | 152390486057 |
| PH | 910.1900 | -3.68% | 114785881280 |
| SO | 93.1200 | -0.67% | 107121523200 |
| SOJE | 15.5500 | 2.78% | 107121523189 |
| SOMN | 48.6900 | -0.08% | 107121523160 |
| ABNB | 176.3700 | 5.64% | 105607837613 |
| CNQ | 49.6400 | -7.39% | 102332860000 |
| DUK | 129.5900 | 2.43% | 101041582180 |
| MNST | 48.7500 | 3.33% | 95503687500 |
| NET | 266.8200 | -2.49% | 95009182352 |
| DUK-PA | 22.6100 | 2.49% | 88127765966 |
| NGG | 85.2200 | 2.89% | 85679676680 |
| CI | 305.4100 | 3.37% | 80701686829 |
| WBD | 30.9500 | 0.00% | 77595880927 |
| EOG | 147.0600 | -5.23% | 77137260623 |
| SPG | 228.5000 | 2.89% | 73931521178 |
| SPG-PJ | 54.5000 | 2.48% | 73637842479 |
| APD | 318.8700 | 1.89% | 71007734951 |
| TRP | 62.6700 | -1.20% | 65287531372 |
| CMI | 471.8400 | -5.76% | 64955611546 |
| TRGP | 285.0000 | -4.54% | 61112840985 |
| CAH | 261.9300 | 3.55% | 60652339236 |
| WPM | 131.5000 | 11.99% | 59722035792 |
| BDX | 209.1900 | 5.56% | 56980636530 |
| NTRA | 391.0300 | 0.62% | 56364628320 |
| SRE | 82.9000 | -2.88% | 54208310000 |
| ROK | 444.1000 | -0.51% | 49416762527 |
| DVN | 44.1200 | -7.35% | 48532000000 |
| TEAM | 189.8800 | -0.61% | 48065998762 |
| MT | 62.4900 | 3.43% | 47120065708 |
| AU | 87.9500 | 8.03% | 44482406065 |
| ED | 120.3000 | 2.99% | 44334159000 |
| LYV | 183.1800 | 2.41% | 42673522126 |
| MCHP | 75.3400 | -3.29% | 40910274780 |
| ONC | 377.7800 | 6.42% | 40368993552 |
| DUKU | 51.1400 | 1.13% | 39873960280 |
| ZTS | 89.1700 | 7.45% | 36847184080 |
| KMB | 108.7900 | 4.15% | 36181269410 |
| IRM | 118.8100 | 1.82% | 35370071094 |
| MCHPP | 64.3500 | -3.55% | 34942629150 |
| MTD | 1723.2400 | 1.48% | 34527870584 |
| AXON | 424.1800 | 1.83% | 34459280332 |
| GMAB | 55.1200 | -0.72% | 33893428005 |
| AEE | 113.0800 | 2.46% | 31305406440 |
| DTE | 137.4400 | 2.37% | 28599614720 |
| DTW | 18.0000 | 2.10% | 28599614712 |
| PBA | 48.7300 | -1.34% | 28339175150 |
| VRSK | 197.8500 | 0.43% | 25751366974 |
| GPN | 96.0900 | -1.95% | 25427143620 |
| TPR | 125.3300 | 3.56% | 24869901413 |
| FWONK | 98.9300 | 3.53% | 24802590718 |
| RL | 412.0600 | 4.48% | 24551456578 |
| USFD | 109.9300 | 8.46% | 23781266830 |
| FWONA | 91.0300 | 3.63% | 22812637599 |
| GH | 168.5800 | -3.67% | 22622790339 |
| AFRM | 75.5900 | 5.03% | 22561952020 |
| VTRS | 19.2200 | 1.59% | 22075916406 |
| SOJD | 17.5700 | 2.09% | 20211825200 |
| EVRG | 86.2100 | 0.89% | 19872525730 |
| BCE | 21.1100 | 2.78% | 19685619997 |
| SOJC | 18.7400 | 2.46% | 18730142348 |
| U | 42.4600 | 4.89% | 18686176095 |
| MTSI | 233.1300 | -1.00% | 17804347917 |
| RGA | 266.6500 | 0.74% | 17412698305 |
| RZC | 25.5900 | 1.15% | 17412698304 |
| JHX | 29.5200 | 8.29% | 17137009440 |
| LAMR | 158.5800 | 1.14% | 16103748413 |
| DUKB | 20.4800 | 1.89% | 15926702080 |
| SBS | 4.6200 | 4.52% | 15789077974 |
| CG | 42.7500 | 4.52% | 15233235750 |
| SOLV | 89.3500 | 5.42% | 15209490186 |
| HALO | 130.3400 | 1.34% | 14793329320 |
| REG | 76.8400 | 2.22% | 14070982831 |
| REGCO | 20.3500 | 0.99% | 14070982815 |
| REGCP | 21.6400 | 1.38% | 13520663301 |
| QXO | 12.6600 | 8.11% | 13134623400 |
| TIGO | 77.0900 | -0.54% | 12915735690 |
| TXRH | 196.4500 | 6.48% | 12895159913 |
| IONQ | 29.5400 | -1.50% | 12684702808 |
| BSY | 43.6400 | 3.58% | 12680823920 |
| AKAM | 85.9300 | -0.69% | 12349601810 |
| SREA | 18.8200 | 2.17% | 12294804880 |
| AHR | 56.3700 | 2.62% | 12266417525 |
| OXLCZ | 25.0900 | 0.12% | 12083344000 |
| MAIR | 23.6100 | -5.56% | 11845670610 |
| OXLCN | 24.5199 | -0.07% | 11808783840 |
| SUZ | 9.5600 | 3.35% | 11788809863 |
| GMED | 87.1000 | 9.45% | 11694212971 |
| FNF | 43.2800 | 4.57% | 11607393040 |
| DKNG | 23.1100 | 5.38% | 11473051940 |
| OXLCL | 23.8000 | -0.25% | 11462080000 |
| GSAT | 84.5800 | 0.97% | 10958438540 |
| WMS | 144.1800 | 6.01% | 10871942210 |
| CPT | 104.4800 | 3.77% | 10502329600 |
| FROG | 86.3400 | -2.43% | 10457476970 |
| ARW | 202.6300 | -2.94% | 10314965862 |
| IAG | 17.4700 | 10.22% | 9975370000 |
| IBRX | 8.9300 | 7.72% | 9464337918 |
| NVMI | 295.3500 | -2.43% | 9393949651 |
| PTGX | 143.3700 | 2.23% | 9277226820 |
| VSAT | 66.7900 | -11.23% | 9200710550 |
| OSCR | 35.1900 | 8.58% | 9123820107 |
| CRNX | 84.9500 | 0.00% | 9012787665 |
| CTRE | 37.9500 | 3.38% | 8967319350 |
| PCTY | 170.9600 | -0.09% | 8919718328 |
| IREN | 21.7100 | -11.24% | 8784159736 |
| QNT | 32.7500 | 0.55% | 8623341225 |
| SARO | 25.7100 | 1.90% | 8507938571 |
| WYNN | 82.3800 | 6.05% | 8482998120 |
| OXLCG | 24.6600 | 0.65% | 8320381974 |
| TXG | 67.5200 | 3.42% | 8116734226 |
| TAP | 43.1550 | 3.07% | 8060792985 |
| GIL | 43.2700 | 6.55% | 8013251263 |
| LNC | 41.6000 | -1.49% | 7964195200 |
| DBX | 36.1000 | 3.26% | 7849678293 |
| CELH | 30.7500 | 2.57% | 7780827695 |
| TAP-A | 43.0300 | -2.45% | 7650773975 |
| COMP | 10.0400 | 7.73% | 7605520880 |
| PRMB | 21.0100 | 2.04% | 7604437242 |
| AG | 15.3900 | 9.15% | 7588515236 |
| LNC-PD | 26.1700 | 0.62% | 7294062909 |
| LYFT | 18.7400 | 12.42% | 7093844266 |
| EPAM | 137.3600 | -0.59% | 7085990320 |
| G | 40.7800 | 1.39% | 6912475478 |
| KTOS | 35.9600 | -12.27% | 6750555040 |
| LNTH | 101.1400 | 0.34% | 6604429358 |
| LOAR | 69.7200 | 1.90% | 6531960128 |
| OTEX | 26.5900 | 3.22% | 6452392152 |
| FTDR | 92.8600 | 4.80% | 6397433324 |
| MP | 35.9100 | -5.08% | 6395628025 |
| BBUC | 30.9500 | 2.72% | 6358430333 |
| TFX | 149.9200 | 7.12% | 6352470208 |
| IBP | 235.4200 | 10.81% | 6257275264 |
| DOCS | 34.6700 | 6.35% | 6179787745 |
| INGR | 97.4700 | 0.71% | 6146846110 |
| AUGO | 72.3900 | 12.92% | 6065501636 |
| STEP | 46.4000 | 4.55% | 5989494770 |
| ACIW | 59.1900 | 1.30% | 5975540715 |
| HAE | 127.4200 | 5.94% | 5797227740 |
| MIDD | 127.5500 | 3.93% | 5768104365 |
| OUT | 32.4800 | 0.37% | 5720864800 |
| NXST | 185.1200 | 3.67% | 5703232496 |
| WTM | 2376.3000 | 3.93% | 5671565112 |
| CON | 43.5600 | 8.49% | 5554672754 |
| LFST | 14.2100 | 6.28% | 5430408340 |
| MAIN | 57.6200 | 2.29% | 5387957523 |
| BGC | 11.2700 | 1.08% | 5253803745 |
| HPP-PC | 13.7400 | 0.15% | 5214288780 |
| HASI | 40.3800 | 5.18% | 5188660000 |
| NSIT | 175.6200 | 4.94% | 5154245037 |
| INSW | 99.3600 | -5.15% | 5082795278 |
| VNT | 37.5800 | 2.79% | 5080816000 |
| NWE | 82.0000 | 2.56% | 5044463700 |
| AAOI | 59.2700 | -7.35% | 5032395749 |
| ATH-PE | 24.4500 | 0.87% | 4982910000 |
| HHH | 79.0600 | 3.62% | 4721420666 |
| VIRT | 53.0300 | -0.38% | 4682584954 |
| SYNA | 117.4900 | 0.07% | 4664515959 |
| FOUR | 44.7700 | 7.91% | 4653178011 |
| WK | 85.2800 | 1.67% | 4640637841 |
| PRM | 28.1300 | -1.44% | 4604513060 |
| NNI | 127.5800 | 4.11% | 4564740700 |
| MC | 61.3500 | 3.60% | 4544862663 |
| KRMN | 34.1700 | -13.52% | 4528676529 |
| ATH-PA | 22.6700 | 1.30% | 4528513860 |
| KTB | 81.9600 | 6.55% | 4479410695 |
| BILL | 51.8700 | 4.11% | 4454074981 |
| MAT | 15.5700 | 1.83% | 4448349000 |
| APLE | 18.8200 | 0.91% | 4443076376 |
| IRTC | 134.0000 | 6.04% | 4417042000 |
| DTK | 21.1400 | 1.88% | 4398980320 |
| PLNT | 57.3400 | 4.20% | 4349194734 |
| COLD | 15.1900 | 4.33% | 4336449570 |
| ICUI | 172.6200 | 6.67% | 4316708340 |
| MDA | 26.2300 | -3.99% | 4252690805 |
| MDU | 19.8200 | 0.87% | 4169117180 |
| CORZW | 6.0401 | -19.79% | 4143573271 |
| IBOC | 66.0100 | -1.98% | 4105260915 |
| CORZ | 12.7600 | -10.39% | 4100304027 |
| CORZZ | 12.8900 | -6.80% | 4100304024 |
| FGN | 22.8000 | 1.97% | 4072292998 |
| PLSE | 57.0600 | 9.31% | 4069667955 |
| CNR | 80.2200 | -3.74% | 3981823986 |
| IOVA | 8.7000 | -1.47% | 3940847700 |
| SPHR | 108.8500 | 3.62% | 3909196340 |
| FA | 22.4700 | 2.98% | 3854437446 |
| LION | 12.7200 | 2.17% | 3784959384 |
| GPGI | 12.7800 | 9.42% | 3704794200 |
| AMLX | 29.4000 | 0.68% | 3690083611 |
| DIOD | 79.4600 | -5.67% | 3659268082 |
| FIGS | 21.9400 | 5.38% | 3645116778 |
| GEO | 27.5300 | -1.92% | 3623498600 |
| AVPT | 16.9000 | 2.80% | 3575455699 |
| APPN | 49.8200 | 2.43% | 3568486883 |
| LMND | 45.9000 | 11.03% | 3552503940 |
| WSC | 19.3000 | -1.48% | 3496985489 |
| DYN | 18.5400 | 2.71% | 3462270840 |
| ATH-PB | 16.8800 | 3.43% | 3440144000 |
| SHOO | 46.9800 | 6.70% | 3437859923 |
| CPK | 141.7000 | 2.64% | 3415884673 |
| CELC | 69.2400 | -0.69% | 3388044756 |
| ALRM | 67.9600 | 3.82% | 3336171895 |
| NMIH | 43.9600 | 1.50% | 3306576730 |
| CARG | 36.5200 | 8.14% | 3252963563 |
| CENX | 32.8000 | -1.59% | 3246980076 |
| TDC | 34.6100 | 2.94% | 3218730000 |
| IRON | 83.2800 | 2.61% | 3197352384 |
| DTG | 15.3600 | 2.06% | 3191869440 |
| AGO | 72.5100 | 1.71% | 3188932372 |
| FSK | 11.4600 | 2.96% | 3166859609 |
| DTB | 15.1600 | 1.27% | 3150308640 |
| BTE | 4.4400 | -7.11% | 3104448000 |
| AAP | 50.7500 | 6.68% | 3065300000 |
| SPNT | 25.8200 | 0.08% | 2999380713 |
| CALY | 16.6000 | 4.53% | 2963282600 |
| ATH-PD | 14.4400 | 1.48% | 2942872000 |
| TR | 39.1200 | 2.73% | 2940378594 |
| SHAK | 72.6800 | 3.62% | 2932691202 |
| FG | 22.1100 | 2.84% | 2929243129 |
| ACMR | 44.4300 | -1.99% | 2872727749 |
| UZE | 15.3300 | 0.62% | 2872499359 |
| PRVA | 22.4000 | 4.33% | 2861241600 |
| UZF | 15.1850 | 1.17% | 2852870031 |
| ACLS | 92.1400 | -5.38% | 2845420396 |
| IMAX | 51.7600 | 2.52% | 2838627821 |
| UZD | 17.1400 | 0.18% | 2823133154 |
| DNOW | 15.4000 | -4.35% | 2784104400 |
| NTCT | 38.1000 | 0.45% | 2770148130 |
| SKWD | 62.2200 | 2.18% | 2762349732 |
| FIVN | 36.3500 | 1.62% | 2716200352 |
| GRDN | 42.0900 | 2.99% | 2665151427 |
| WRBY | 21.2900 | -2.96% | 2631615385 |
| ZLAB | 22.8000 | 3.83% | 2571961022 |
| LCII | 104.1840 | 2.29% | 2532870045 |
| MBX | 52.4800 | -4.58% | 2527441786 |
| PBH | 53.2800 | 7.55% | 2524113360 |
| TMDX | 72.7550 | 8.04% | 2522786901 |
| SEAL-PA | 25.1900 | 0.60% | 2516463669 |
| TRTN-PA | 24.7500 | 0.67% | 2503730419 |
| ABXL | 25.4400 | 0.39% | 2486833776 |
| DXPE | 158.3800 | -11.76% | 2457598298 |
| BHF | 42.4500 | -0.34% | 2441365849 |
| MH | 12.7600 | 4.50% | 2441100288 |
| GRND | 14.0100 | 7.19% | 2435232210 |
| PAYO | 7.1600 | 0.00% | 2426171986 |
| OXLCM | 24.7999 | -0.00% | 2420470240 |
| BOBS | 18.3300 | 7.57% | 2395493993 |
| NOG | 22.2700 | -10.85% | 2372849081 |
| DCO | 156.3300 | -6.22% | 2360548451 |
| PLUS | 90.4700 | 0.69% | 2360400116 |
| TRTN-PB | 23.3200 | 2.06% | 2359070439 |
| PVLA | 162.2800 | 6.11% | 2338195152 |
| PENN | 17.4400 | 2.17% | 2336396182 |
| VCEL | 45.4800 | 10.68% | 2328876168 |
| PTON | 5.4600 | 2.82% | 2309771520 |
| VERA | 31.9700 | 4.10% | 2303863701 |
| IMNM | 19.5200 | -3.89% | 2303418560 |
| HLIO | 66.9500 | -2.16% | 2206042670 |
| SEAL-PB | 25.2600 | 0.48% | 2197771560 |
| NWN | 51.3200 | 2.23% | 2160238420 |
| TRTN-PC | 21.1900 | 1.97% | 2143556900 |
| XRAY | 10.6500 | 9.46% | 2123120100 |
| LPG | 49.4300 | -4.87% | 2114747922 |
| BKV | 19.1000 | -3.63% | 2090262553 |
| CTRI | 20.5400 | -6.55% | 2073781047 |
| SOUNW | 0.3200 | 13.27% | 2072628106 |
| GCT | 57.8800 | 5.77% | 2066908518 |
| SRPT | 18.9900 | 2.43% | 2005856730 |
| BL | 34.3900 | 3.15% | 1998929067 |
| NGL-PB | 25.1100 | 0.12% | 1990290967 |
| NGL-PC | 25.2000 | 0.00% | 1986640387 |
| TRTN-PD | 19.6000 | 2.08% | 1982744212 |
| TRLV | 11.6000 | 0.52% | 1973843426 |
| ASTH | 39.6700 | 8.00% | 1967805199 |
| DRVN | 11.9100 | 5.54% | 1964909609 |
| ZD | 56.7500 | 5.11% | 1945799054 |
| SOUN | 4.3200 | 4.85% | 1940596605 |
| NGL | 15.5200 | -5.19% | 1937113280 |
| OPEN | 1.9800 | 13.79% | 1922760180 |
| AGM | 205.5800 | 1.65% | 1916443485 |
| SVM | 8.6400 | 8.68% | 1911222510 |
| XERS | 10.4600 | 1.06% | 1907067200 |
| LASR | 32.9900 | -9.64% | 1903199599 |
| TGLS | 42.8100 | 8.05% | 1899249211 |
| BLFS | 38.6100 | 0.00% | 1886384793 |
| AGM-PE | 18.4707 | 1.94% | 1878923036 |
| PRDO | 29.9900 | 1.11% | 1876687229 |
| GENI | 7.0100 | 3.09% | 1876064969 |
| AGIO | 31.3800 | 0.58% | 1873445057 |
| AGM-PG | 15.8600 | 0.60% | 1868662249 |
| ARHS | 13.1500 | 9.04% | 1861251828 |
| ZBIO | 28.4600 | 0.28% | 1854929451 |
| MAZE | 33.3800 | 3.50% | 1854231228 |
| AMN | 47.7400 | 5.39% | 1848970200 |
| AGM-PF | 16.6900 | 0.18% | 1837557651 |
| AGM-A | 142.0000 | 2.90% | 1832317448 |
| HIMX | 10.4400 | -2.43% | 1821006542 |
| GENB | 14.1600 | 2.24% | 1817470409 |
| SNDA | 37.0100 | 8.73% | 1778256110 |
| NVAX | 10.6500 | 10.02% | 1756671982 |
| ICFI | 96.9100 | -0.76% | 1737974249 |
| ATEN | 23.8100 | -2.02% | 1728820290 |
| NTLA | 12.3100 | 3.79% | 1724959591 |
| CERT | 11.0900 | 2.02% | 1691657510 |
| PDFS | 39.7900 | -5.69% | 1680220288 |
| MNR | 10.0200 | -3.19% | 1672819862 |
| IQMX | 8.8000 | 3.77% | 1667566718 |
| STRA | 74.3200 | 0.38% | 1650468832 |
| ANIP | 71.6500 | -0.87% | 1645047315 |
| ARLO | 15.2200 | 11.01% | 1637874487 |
| HUBG | 26.9600 | 0.41% | 1633199245 |
| DSGR | 35.0200 | 0.06% | 1620956732 |
| GEL | 13.2600 | -7.98% | 1620561870 |
| KRP | 15.4800 | -5.15% | 1561869832 |
| SVV | 10.0600 | 8.17% | 1551816668 |
| PRKS | 34.1900 | 5.04% | 1550219355 |
| LSPD | 11.5600 | 5.28% | 1538670680 |
| CBL | 49.7000 | 0.75% | 1537855023 |
| SMR | 5.1300 | -4.47% | 1529652822 |
| MBC | 7.5100 | 9.00% | 1528213580 |
| ATLC | 99.7500 | 7.85% | 1513207500 |
| ATLCL | 25.0200 | 0.10% | 1513207498 |
| ATLCZ | 25.2200 | 0.28% | 1513207490 |
| IMCR | 29.2300 | -2.66% | 1505304575 |
| EVCM | 8.5200 | 2.04% | 1505187896 |
| INOD | 43.3000 | 3.34% | 1488768788 |
| VISN | 6.4400 | -1.08% | 1485231440 |
| TRUP | 33.6750 | 8.21% | 1468919395 |
| WEN | 7.6500 | 5.23% | 1458624965 |
| PCRX | 36.4000 | 0.03% | 1450972578 |
| ETON | 50.7200 | -0.45% | 1449734832 |
| CRSR | 13.3200 | 8.20% | 1440917094 |
| ENOV | 24.4200 | 16.90% | 1408289043 |
| NUTX | 205.2200 | 14.28% | 1405341019 |
| SG | 11.8000 | 3.42% | 1404687482 |
| GHRS | 19.9300 | -1.73% | 1368040780 |
| DMLP | 27.8050 | -1.44% | 1364986377 |
| TNDM | 19.0500 | 7.93% | 1325474235 |
| LBRX | 40.8500 | 1.29% | 1317787258 |
| WD | 38.3400 | 9.01% | 1316049063 |
| BJRI | 61.7500 | 1.86% | 1313654989 |
| PURR | 9.6900 | -4.63% | 1304274000 |
| VYX | 9.4300 | 7.16% | 1301999138 |
| CRON | 3.5100 | 3.85% | 1293129630 |
| ROCK | 43.5800 | 6.60% | 1292666430 |
| AORT | 26.4500 | 11.56% | 1289601490 |
| KEEL | 2.1150 | -3.42% | 1277098335 |
| MNKD | 3.9300 | 5.36% | 1263669822 |
| ATLCP | 20.8800 | 1.04% | 1259738027 |
| CCO | 2.4200 | -0.41% | 1232007105 |
| CRAI | 194.7500 | -0.26% | 1222418485 |
| MSDL | 14.4200 | 2.71% | 1212795903 |
| YELP | 22.0500 | 11.20% | 1196512843 |
| AMPH | 28.0200 | 3.32% | 1191913191 |
| OMDA | 19.4300 | 4.57% | 1189440481 |
| TRIP | 10.2000 | 8.05% | 1186883924 |
| GPCR | 20.3600 | 0.05% | 1172057320 |
| SCSC | 56.9800 | 0.42% | 1160555364 |
| SGP | 34.4500 | 0.00% | 1152282877 |
| WLDN | 74.2000 | -0.59% | 1130221152 |
| JANX | 18.1800 | 2.02% | 1111466533 |
| CSTL | 35.7500 | 1.74% | 1092144625 |
| ECVT | 9.9700 | -0.80% | 1091395960 |
| KRT | 53.6300 | 2.80% | 1068938197 |
| LOMA | 8.9100 | 0.11% | 1039766706 |
| RHLD | 130.8400 | 8.85% | 1023115810 |
| WEST | 10.3600 | 9.40% | 1011419729 |
| GSBD | 8.9400 | 1.25% | 1006367459 |
| HEPS | 2.8000 | 0.00% | 1000230540 |
| RIGL | 51.2900 | 4.97% | 958090225 |
| NABL | 5.0700 | 0.60% | 957751007 |
| GPRE | 13.6600 | -2.91% | 957501798 |
| LCLN | 27.2500 | 5.25% | 949579987 |
| NXDR | 2.4400 | 5.17% | 943910079 |
| CIM-PD | 20.7400 | -0.10% | 942322709 |
| CIM-PC | 19.2900 | -1.18% | 938474048 |
| SLN | 19.8000 | 0.10% | 935232170 |
| CIM-PB | 20.8300 | -0.33% | 933540651 |
| BBDC | 8.9100 | 2.53% | 932938336 |
| GLIBK | 23.2700 | 1.53% | 929633870 |
| GLUE | 10.8200 | 3.94% | 923090988 |
| GLIBA | 23.0700 | 1.67% | 921643893 |
| CIM-PA | 18.2800 | 1.84% | 915166447 |
| PSIX | 39.6700 | -19.75% | 915004418 |
| HOS | 6.1400 | -1.76% | 904440217 |
| ASTE | 39.3000 | -1.90% | 903610359 |
| VSTM | 9.8500 | 0.82% | 892049894 |
| TDAY | 6.0700 | 6.12% | 891185260 |
| KRO | 7.7400 | 3.06% | 890854774 |
| AIP | 18.1000 | -2.84% | 889653046 |
| CRVS | 10.5700 | 7.53% | 889157913 |
| ABX | 9.0500 | 4.99% | 885019853 |
| GOOS | 8.9100 | 7.74% | 870156026 |
| KBDC | 13.0000 | 0.78% | 858491530 |
| MFICL | 25.4000 | 0.12% | 850909246 |
| CYRX | 16.7000 | 1.52% | 845839970 |
| OXLCO | 23.8000 | 1.19% | 823941720 |
| GHM | 69.7800 | -5.60% | 819007860 |
| FUN | 7.9500 | 6.57% | 813412180 |
| PLTK | 2.1200 | 5.47% | 808606160 |
| LYTS | 21.3900 | 1.57% | 797947533 |
| PAR | 19.0000 | 4.80% | 785891300 |
| DNA | 11.6500 | 8.27% | 784514239 |
| EOSE | 2.1400 | 12.63% | 774010901 |
| COLL | 23.6700 | -0.25% | 770591052 |
| PSNY | 4.7100 | 7.53% | 769066274 |
| CGEM | 12.4900 | -20.70% | 767610995 |
| SANA | 2.5600 | 4.92% | 766363231 |
| PRAA | 20.1800 | 1.51% | 759736761 |
| CGBD | 11.0400 | 2.41% | 759602784 |
| NRDS | 11.8100 | 8.95% | 754932697 |
| FDUS | 19.7000 | 1.39% | 747700971 |
| BFS-PE | 18.6600 | 1.41% | 741073858 |
| EDN | 14.9000 | -0.13% | 734654781 |
| FOXF | 17.3700 | 7.42% | 728430630 |
| CIM | 8.6800 | 4.70% | 726047436 |
| ACDC | 3.9700 | -4.80% | 723027357 |
| JBGS | 12.2900 | 4.86% | 719894997 |
| BFS-PD | 18.8600 | 0.00% | 719726776 |
| BFS | 29.1000 | 1.50% | 719267610 |
| ACHV | 6.9800 | 3.71% | 718255960 |
| HTZWW | 1.0400 | 0.00% | 713627822 |
| HTZ | 2.2600 | 9.18% | 713627822 |
| AGNT | 4.2700 | 8.93% | 713593591 |
| CARS | 12.7500 | 10.29% | 712763594 |
| VTEX | 4.1900 | 5.54% | 704657934 |
| SABR | 1.7400 | 4.19% | 702234420 |
| CLDT | 14.9800 | -0.27% | 697552898 |
| AURA | 6.6500 | 6.57% | 689636980 |
| BKSY | 16.7700 | -3.84% | 686309667 |
| CCSI | 37.1800 | 2.99% | 681320637 |
| EVC | 7.2800 | 5.20% | 671858875 |
| LXRX | 1.4800 | 1.37% | 658534782 |
| PZZA | 19.9900 | 7.70% | 658104523 |
| PRTH | 7.9200 | 0.13% | 653179824 |
| UMAC | 13.0300 | -10.88% | 650933260 |
| CLDT-PA | 18.8000 | 0.00% | 650752619 |
| AOSL | 21.1700 | -4.38% | 641558353 |
| OXLC | 6.5200 | 0.77% | 639156904 |
| OXLCI | 25.1800 | 0.20% | 639156883 |
| IRWD | 3.7700 | 7.71% | 622954600 |
| OBE | 9.2100 | -11.87% | 614542776 |
| DNUT | 3.5200 | 7.65% | 610720000 |
| GRNT | 4.6300 | -9.39% | 610697000 |
| LUCK | 4.4200 | 5.49% | 602569853 |
| IBEX | 44.7000 | 0.65% | 596488511 |
| KELYA | 16.9100 | 3.36% | 587317173 |
| EVEX | 1.6800 | 9.80% | 585456480 |
| KELYB | 25.5500 | -4.09% | 583393344 |
| NVRI | 20.5100 | 7.78% | 578179341 |
| HPP | 10.5600 | 6.99% | 573077472 |
| EGY | 5.4000 | -3.74% | 568035601 |
| MSIF | 12.3400 | 3.26% | 559560138 |
| EVO | 1.5700 | 1.29% | 557634148 |
| PBYI | 10.6900 | 4.60% | 551818506 |
| GAU | 2.0800 | 10.64% | 544110869 |
| ACRS | 3.6800 | -1.60% | 541692320 |
| FLGT | 19.6800 | 1.60% | 541501104 |
| EVH | 4.8000 | 11.63% | 539909122 |
| HY | 30.0200 | 2.70% | 538270248 |
| CLYM | 9.3300 | -4.31% | 535880259 |
| AGM-PD | 18.0201 | 1.12% | 528037584 |
| ISOU | 8.0700 | 0.12% | 526619148 |
| YORW | 32.2600 | 1.80% | 523533959 |
| SOJF | 23.0200 | 1.41% | 520252000 |
| STTK | 5.1500 | -5.85% | 516869450 |
| CBIO | 13.8200 | 5.82% | 513329251 |
| CTMX | 2.3500 | 7.80% | 512062650 |
| RGNX | 7.7100 | 1.05% | 508961710 |
| ITIC | 268.8900 | 0.68% | 507663244 |
| LOCO | 16.4700 | 5.92% | 501230472 |
| PANL | 7.5100 | -0.79% | 491708028 |
| MBUU | 24.7500 | 2.65% | 487025550 |
| HNST | 4.4400 | 2.07% | 476342643 |
| FVR | 19.3000 | 2.77% | 471999893 |
| KRUS | 37.7900 | 3.82% | 459142302 |
| SSII | 2.2700 | -2.58% | 455085060 |
| ARKO | 4.0400 | 5.21% | 453230313 |
| GNE | 17.1340 | 2.60% | 450960438 |
| TCI | 50.5800 | 2.00% | 443787150 |
| TRC | 16.2800 | -0.12% | 439908392 |
| SI | 21.0100 | 6.00% | 437406266 |
| VHI | 15.2100 | 4.11% | 430765346 |
| PRTA | 8.3900 | 2.19% | 430717430 |
| ACTG | 4.3600 | 2.11% | 425478448 |
| CICC | 24.3100 | 0.50% | 416742854 |
| GLOP-PB | 25.8800 | -1.15% | 415027234 |
| QVCG | 8.2900 | 3.88% | 414499146 |
| ALT | 2.1200 | 3.92% | 412377526 |
| ALLO | 1.1900 | 6.25% | 411134148 |
| GLOP-PC | 25.4000 | -0.59% | 407329665 |
| RCEL | 16.3200 | 6.46% | 405436128 |
| GLOP-PA | 25.0256 | -0.49% | 401325587 |
| ASPN | 4.8000 | -3.23% | 398346163 |
| TECX | 20.3000 | 6.95% | 396852130 |
| PTLO | 5.4500 | 4.61% | 395226795 |
| CCCC | 3.1200 | -2.80% | 383838000 |
| RZLT | 3.9600 | -1.25% | 383020439 |
| AVTX | 7.0700 | -2.48% | 379164022 |
| EOSEW | 1.2000 | -4.76% | 378084706 |
| MOBI | 11.2400 | 12.74% | 374191919 |
| REAX | 16.9900 | 11.56% | 370287094 |
| FNKO | 6.5600 | 4.46% | 367332225 |
| TCPC | 4.3700 | 4.05% | 366655236 |
| WRN | 1.6000 | 2.56% | 361880000 |
| NL | 7.3600 | 7.60% | 359894432 |
| GTE | 10.0500 | -2.05% | 355569000 |
| SLI | 1.4400 | 5.11% | 355368960 |
| ARTNA | 33.8500 | 0.21% | 349573012 |
| HLLY | 2.9000 | 7.41% | 348407131 |
| CCOI | 6.7900 | 14.89% | 347754603 |
| CION | 7.0500 | 3.22% | 346879070 |
| ARL | 21.4600 | 10.33% | 346621920 |
| INDI | 1.5900 | 6.00% | 346506690 |
| CLNE | 1.5700 | 0.64% | 346098650 |
| FIP | 2.7500 | 3.00% | 324949776 |
| ARI | 2.5100 | 4.15% | 322646326 |
| AGEN | 6.9700 | 4.50% | 314778443 |
| REI | 1.2000 | -6.98% | 312647528 |
| ARCT | 10.8700 | 13.94% | 308958760 |
| TBCH | 16.9600 | 7.21% | 303748699 |
| SPRY | 3.0500 | 0.00% | 303314265 |
| BLND | 1.2800 | 10.34% | 302737024 |
| KINS | 20.0800 | 0.70% | 290680751 |
| KWY | 10.0100 | 1.83% | 289599310 |
| SABS | 3.1800 | 1.92% | 289336650 |
| NREF-PA | 24.6250 | 2.26% | 287838227 |
| LRMR | 2.7600 | 8.66% | 286717080 |
| RCKT | 2.6100 | 3.98% | 286511698 |
| NNDM | 1.3200 | -2.94% | 286401595 |
| CMRC | 3.4500 | 4.55% | 285863519 |
| FRD | 38.7900 | -5.51% | 279784124 |
| FGSN | 18.4500 | 2.61% | 276750000 |
| NREF | 14.6400 | 1.46% | 275935145 |
| RWAY | 6.5600 | 1.55% | 274928970 |
| RWAYL | 25.3500 | 0.00% | 274928963 |
| PESI | 12.8100 | -1.84% | 271807076 |
| HTFC | 25.0000 | -0.01% | 271289500 |
| HRZN | 4.0300 | 4.40% | 270146617 |
| RMAX | 12.3600 | -9.25% | 263487291 |
| INFU | 13.1500 | 2.73% | 261911180 |
| PROF | 7.1600 | 2.43% | 261573416 |
| LCTX | 1.0300 | 1.98% | 260494210 |
| QSI | 1.2900 | -0.77% | 256640871 |
| CNDT | 1.6500 | 10.74% | 256609320 |
| ONIT | 30.7000 | 7.04% | 256483764 |
| ALEC | 2.2800 | 11.22% | 254577775 |
| BRT | 13.1300 | 3.30% | 246756029 |
| AIV | 1.6900 | 2.42% | 245450358 |
| KRRO | 16.6200 | 4.79% | 244739472 |
| FATE | 2.0900 | 2.45% | 243608699 |
| NUS | 4.9900 | 6.17% | 242896234 |
| CABA | 1.4200 | 0.00% | 240753900 |
| ASLE | 4.9700 | 1.02% | 237202012 |
| SSP | 2.8800 | 7.06% | 232520455 |
| SERV | 2.6500 | 1.53% | 229774886 |
| EXFY | 2.3800 | 3.93% | 229522723 |
| BIOA | 5.9500 | -0.17% | 224015328 |
| TROO | 1.8100 | -11.27% | 221109600 |
| KDK | 1.1000 | -5.17% | 220679976 |
| CIA | 4.1300 | 8.12% | 209156003 |
| RNAC | 6.8200 | 6.40% | 206341501 |
| LCUT | 8.8900 | 4.71% | 204370432 |
| UPB | 3.7000 | 9.14% | 202652848 |
| PRQR | 1.4100 | 2.92% | 198977835 |
| TRDA | 5.0600 | 7.20% | 197019545 |
| TSSI | 6.8500 | -2.56% | 193300630 |
| SWKHL | 25.2100 | 0.12% | 193015121 |
| AKBA | 0.6947 | -4.28% | 192505538 |
| INGN | 7.2200 | 2.85% | 191606793 |
| XPOF | 4.5300 | -0.44% | 191252070 |
| RCD | 20.1000 | 2.45% | 189332071 |
| RC | 1.1400 | 4.59% | 188317740 |
| DIBS | 5.5600 | 7.96% | 186901068 |
| IVVD | 0.6336 | 8.96% | 186759141 |
| STRW | 13.0800 | 4.39% | 185177955 |
| IMPPP | 25.9592 | 0.77% | 184149010 |
| WHG | 19.2400 | 2.23% | 182481203 |
| CRNT | 2.0000 | -1.48% | 181787400 |
| FLWS | 2.8300 | 4.81% | 181398707 |
| FIRY | 11.5900 | -7.21% | 180890427 |
| WHWK | 3.1700 | 2.26% | 180718530 |
| GPRO | 0.9450 | -2.00% | 178070130 |
| RC-PE | 10.3300 | 0.88% | 176875032 |
| RC-PC | 9.9900 | 4.28% | 175737417 |
| BDSX | 21.4900 | 2.09% | 174934596 |
| IMPP | 4.6200 | -5.71% | 173672347 |
| EPSN | 5.5900 | -4.12% | 169286325 |
| CLAR | 4.4200 | -2.86% | 169233844 |
| STRO | 9.9400 | 4.52% | 164816840 |
| PLBY | 1.3700 | 3.40% | 164136533 |
| FOCL | 4.3400 | 5.60% | 162671819 |
| SSTK | 4.3600 | 6.86% | 161091902 |
| ANTX | 4.2500 | 1.67% | 160379007 |
| EGAN | 6.1800 | 3.87% | 156434958 |
| RILY | 3.8300 | 1.86% | 153965234 |
| IPHA | 1.4250 | 7.14% | 149246596 |
| ONL | 2.4800 | 0.40% | 141470891 |
| TCX | 12.5500 | 3.55% | 140335355 |
| GSIT | 3.6400 | -4.21% | 139894628 |
| YARW | 14.9100 | -18.84% | 138728023 |
| DH | 1.2300 | 5.13% | 131295993 |
| KVHI | 7.0900 | -3.67% | 128619690 |
| MRDN | 10.0600 | 4.25% | 127169084 |
| HSDT | 2.1000 | 1.94% | 122612018 |
| WW | 12.1300 | -6.55% | 121284959 |
| HCAT | 1.5900 | 10.42% | 119657646 |
| NXH | 1.7100 | 1.18% | 116584780 |
| MCN | 5.4000 | 0.56% | 113364900 |
| OPHC | 8.9500 | -2.40% | 112971106 |
| ORGO | 0.8700 | 4.19% | 111946857 |
| UP | 3.0700 | -4.06% | 111349063 |
| APYX | 2.5900 | -0.38% | 109101160 |
| BDTX | 1.9000 | 4.97% | 108873371 |
| KLXE | 1.0100 | -2.88% | 106733770 |
| NMRA | 0.5660 | -0.86% | 106349079 |
| JYNT | 7.5100 | 4.31% | 106215432 |
| PYXS | 1.6600 | 1.22% | 105170097 |
| INSE | 3.7600 | -0.53% | 100299335 |
| SRFM | 0.7399 | -0.28% | 98294768 |
| BRLT | 1.5300 | 2.00% | 97814058 |
| FEAM | 2.3200 | 3.57% | 96621901 |
| VTVT | 24.0300 | 2.04% | 95012890 |
| STHO | 7.8100 | 0.00% | 94413302 |
| AMTX | 1.2500 | 8.70% | 90211993 |
| NYXH | 0.8594 | -1.22% | 87521296 |
| HMR | 1.4200 | -1.39% | 83768636 |
| UBCP | 14.3400 | 2.06% | 82247357 |
| SUIG | 1.0600 | -2.75% | 81411044 |
| BZFD | 0.9207 | 0.08% | 80654589 |
| RGS | 31.7700 | 9.10% | 79429988 |
| OESX | 19.0000 | -8.61% | 77696434 |
| CCLD | 1.8000 | 4.65% | 76488946 |
| IOR | 18.5200 | 0.00% | 75305617 |
| BARK | 8.3300 | 2.33% | 75248697 |
| OPENW | 0.0773 | 4.32% | 75065334 |
| BCIC | 6.0300 | 0.92% | 74673422 |
| SKIN | 11.0500 | 6.76% | 71902770 |
| AFCG | 3.1900 | 3.24% | 71675472 |
| WRAP | 1.1600 | -0.85% | 71660719 |
| CRDF | 0.8689 | 0.67% | 67596249 |
| OPENL | 0.0690 | 2.07% | 67005279 |
| UEIC | 5.1800 | -1.52% | 66744616 |
| BLNK | 0.4514 | 6.21% | 65543731 |
| CGTX | 0.6833 | -2.32% | 64977553 |
| XXI | 5.8300 | 5.81% | 60049000 |
| MKTW | 21.3500 | 2.40% | 59624359 |
| RNXT | 1.3100 | 1.55% | 59119645 |
| APT | 5.7400 | 3.24% | 58583691 |
| THRY | 1.3000 | 4.00% | 57770830 |
| XLO | 8.7100 | 0.35% | 57313133 |
| COCH | 7.1200 | 7.55% | 55104948 |
| BOLD | 2.4000 | 0.84% | 54595166 |
| DTI | 1.5000 | 1.35% | 52923335 |
| PLRX | 0.8518 | -1.03% | 52745072 |
| LINK | 3.3200 | -5.14% | 52301288 |
| ATLX | 1.7300 | 9.84% | 52072654 |
| OPENZ | 0.0523 | 1.36% | 50788059 |
| MATH | 1.0400 | 5.07% | 49439505 |
| TENX | 1.8100 | -1.63% | 48010538 |
| LIDR | 1.0100 | 0.00% | 47138891 |
| CTM | 0.4900 | 2.08% | 46442830 |
| RWAYM | 25.0010 | -0.19% | 45001800 |
| WATT | 8.1400 | -4.91% | 44990350 |
| SCWO | 2.5300 | -0.39% | 44590618 |
| HGBL | 1.2800 | 2.40% | 44338490 |
| CVRX | 1.5800 | 14.49% | 42093723 |
| ACFN | 16.1000 | -1.29% | 40404834 |
| DOMH | 1.6400 | -1.20% | 39759579 |
| MLCI | 3.5500 | 0.00% | 39720126 |
| DWTX | 1.0300 | -0.96% | 39374737 |
| RANI | 0.5728 | 3.06% | 37415296 |
| STRRP | 9.0000 | 1.12% | 37192248 |
| PHUN | 1.7900 | 1.13% | 37010577 |
| INMB | 1.3300 | 0.76% | 36912541 |
| NTIP | 1.6000 | 4.58% | 36581120 |
| NEPH | 3.2500 | 0.31% | 35327500 |
| ELUT | 0.7596 | -6.59% | 33642076 |
| AERT | 5.9800 | 4.73% | 32250349 |
| UG | 6.8600 | 0.44% | 31517028 |
| ALGS | 5.0200 | 5.68% | 31347681 |
| RAVE | 2.1900 | 1.39% | 31123330 |
| CABO | 5.2600 | 8.01% | 29844819 |
| HHS | 3.9700 | 0.00% | 29593333 |
| FLL | 0.7945 | 4.73% | 29114039 |
| STEM | 2.8800 | 21.52% | 27725011 |
| FLNA | 0.5720 | -3.75% | 27632117 |
| TEAD | 0.2753 | 9.68% | 26997339 |
| ORIO | 1.0200 | 6.81% | 24256620 |
| MSGM | 4.4300 | -5.94% | 23961077 |
| NFE | 4.0800 | -2.63% | 23307775 |
| QRHC | 1.0550 | 4.46% | 22252963 |
| ACH | 0.2754 | -2.62% | 21179555 |
| CIRC | 0.2327 | -5.02% | 20933692 |
| LONA | 4.5650 | -4.30% | 18004483 |
| ACHR-WT | 0.0072 | -48.57% | 16882043 |
| MRKR | 1.0100 | 2.76% | 16839831 |
| MERC | 0.2500 | 17.92% | 16754500 |
| BGDE | 2.7700 | -12.06% | 15838999 |
| ATYR | 6.1800 | -6.79% | 15154534 |
| KDKRW | 0.2261 | 12.99% | 13986480 |
| IQMXW | 1.1000 | 2.80% | 13784073 |
| REFR | 0.3849 | 10.10% | 13420611 |
| PLUR | 1.2300 | -3.15% | 13271085 |
| CDLX | 2.1900 | 4.78% | 12896288 |
| BOLT | 6.5400 | -0.46% | 12598296 |
| LPCN | 1.4400 | -1.37% | 11871720 |
| SINT | 1.6600 | -3.49% | 11812487 |
| LIQT | 0.3150 | 1.55% | 10378570 |
| BIRD | 1.6300 | 2.52% | 10227968 |
| PHIO | 0.8699 | -3.67% | 10105846 |
| LSTA | 1.0600 | -2.75% | 9551596 |
| BKSY-WT | 0.0021 | -66.67% | 9496904 |
| INTS | 3.5000 | 3.55% | 9459870 |
| INAB | 0.9307 | -2.02% | 9175194 |
| XOSWW | 0.0032 | -60.00% | 8922759 |
| MTVA | 1.3400 | 6.35% | 8828055 |
| BRFH | 0.5410 | 0.19% | 8822721 |
| QNRX | 4.0200 | 2.29% | 8072482 |
| INUV | 0.4425 | -0.34% | 7293762 |
| CNSY | 0.8916 | -31.42% | 6766910 |
| PSQH | 1.9200 | -32.63% | 6462298 |
| INBS | 1.7500 | -1.13% | 5804405 |
| PULM | 1.5200 | 14.29% | 5551473 |
| PCSA | 1.9350 | -0.26% | 5414594 |
| VEEE | 9.0900 | 1.22% | 5308324 |
| DSS | 0.5284 | 3.00% | 5306457 |
| TWAV | 1.3100 | -2.24% | 5079157 |
| NWTG | 0.9099 | 12.53% | 4324266 |
| HYFM | 0.7550 | 12.77% | 3638587 |
| HCTI | 4.6200 | -11.83% | 3459068 |
| XPON | 3.3900 | -8.38% | 3231317 |
| APVO | 1.3700 | 0.74% | 2995994 |
| VIVS | 0.1522 | 5.99% | 2524465 |
| REVB | 4.1177 | -7.05% | 2343214 |
| CRIS | 1.1100 | 55.48% | 2164500 |
| ISPC | 0.8430 | 6.75% | 2123171 |
| GOVX | 0.1680 | 2.38% | 1697282 |
| STLNW | 0.0151 | -31.36% | 1509742 |
| EZRA | 2.4000 | 0.00% | 1333834 |
| DRCT | 0.9100 | 0.00% | 692116 |
| COCHW | 0.0252 | 0.00% | 524160 |
| RKDA | 0.1582 | 2.06% | 244786 |
| LIDRW | 0.0026 | 0.00% | 120395 |
| REVBW | 0.0055 | 14.61% | 32583 |
| JSPRW | 0.0002 | -84.62% | 3251 |
| CIMO | 24.6800 | 0.53% | 0 |
6-K/8-K Form Update
FLNA
Filana Therapeutics, Inc. reported third-quarter financial results ending September 30, 2026, with cash and cash equivalents at $47.0 million and no debt, while research and development expenses decreased to $3.9 million from $4.0 million in the same period in 2025. The company lifted the FDA clinical hold on its investigational new drug application for simufilam in Tuberous Sclerosis Complex-related epilepsy, paving the way for Phase 2a study preparations expected to enroll approximately 40 patients across 13 clinical sites in the U.S. by the first quarter of 2027. New preclinical research published in October provided insights into simufilam's potential mechanism of action, evaluating its effects on cellular stress-related signaling and mitochondrial function in TSC2-deficient human cells.
ACLS
Axcelis Technologies, Inc. reported third-quarter financial results with revenue of $237.8 million, a GAAP gross margin of 41.0%, and a Non-GAAP gross margin of 41.2%, resulting in GAAP net income of $37.8 million and diluted earnings per share of $1.21. The company's performance was driven by improving demand, leading to growth in systems and record CS&I revenue, despite foreign exchange headwinds. Axcelis anticipates positive momentum into 2027, with fourth-quarter revenue guidance of approximately $275 million and earnings per diluted share of $1.15 GAAP and $1.50 non-GAAP.
GPJA
Southern Company reported third-quarter 2026 earnings of $2.0 billion, or $1.77 per share, up from $1.7 billion, or $1.55 per share, in the same period in 2025. Operating revenues rose 13.0% to $8.8 billion, with nine-month revenues increasing 7.3% to $24.2 billion. Earnings were driven by warmer weather, increased usage, customer growth, and higher revenue from commercial and industrial customers, partially offset by higher operating expenses and taxes.
INM
Mentari Therapeutics, Inc. (formerly InMed Pharmaceuticals Inc.) completed its share consolidation, reducing outstanding shares to approximately 549,374, and announced its trading on The Nasdaq Capital Market under the existing symbol "INM" with new identifiers. The company, having legally changed its name effective November 4, 2026, also plans to issue contingent value rights (CVRs) to shareholders, contingent on the terms of the CVR Agreement. These changes follow shareholder approval of several proposals, including a merger that positions Mentari as a wholly owned subsidiary, pending closing conditions.
VCEL
Vericel Corporation reported third quarter 2026 financial results, with total net revenue growing 26% to $85.4 million and net income surging 179% to $14.2 million. The company raised its full-year revenue guidance to $344 to $346 million and adjusted EBITDA margin guidance to 28%. Vericel also authorized a $191.2 million share repurchase, having bought back 220,744 shares for $8.8 million during the quarter.
LFCR
Lifecore Biomedical, Inc. (LFCR) agreed to merge with Lifecore Inc. and Hazel Merger Sub, Inc., with LFCR set to become a wholly owned subsidiary of Lifecore Inc. The merger's closing is contingent upon stockholder approval at a special meeting, following the early termination of the Hart-Scott-Rodino waiting period by the Department of Justice and the Federal Trade Commission. The transaction is subject to remaining closing conditions and approvals.
GSAT
Globalstar, Inc. reported its third-quarter financial results for 2026, achieving a total revenue of $70.9 million, driven by $65.4 million in service revenue. The company successfully launched its first set of HIBLEO-4 replacement satellites, marking a significant milestone in enhancing its mobile satellite services network. Despite a net loss of $15.7 million for the quarter, Globalstar received key regulatory authorization from the FCC for its next-generation C-3 satellite constellation.
CRMT
America's Car-Mart, Inc. secured compliance with a First Amendment and Limited Waiver to its Credit and Guaranty Agreement with Silver Point Finance, LLC, as Administrative Agent and Collateral Agent, and the lenders. The amendment provides temporary relief from certain events of default until November 9, 2026, allowing the company to maintain minimum liquidity thresholds and Collateral Coverage Ratio obligations. This adjustment follows the original Credit Agreement dated October 30, 2025, and aims to support the company's financial stability during the specified period.
RDN
Radian Group Inc. reported a robust financial performance for the quarter ended September 30, 2026, with net income from continuing operations reaching $172 million, or $1.28 per diluted share, up from $153 million, or $1.11 per diluted share, in the same period in 2025. Total revenues surged 106% year-over-year to $624 million, while net premiums earned increased 9% to $548 million, driven by strong underwriting in the Specialty segment. The company's book value per share grew 4.2% to $35.78, and it repurchased $379 million of shares, representing 8% of shares outstanding.
HOMB
Home BancShares, Inc. received approximately $80.7 million from the sale of collateral securing a $92.1 million non-performing loan. The proceeds, covering about 95% of the collateral's appraised value, reduced the loan's principal balance to roughly $11.4 million. This transaction decreased the company's non-performing loan ratio by 48 basis points and non-performing asset ratio by 34 basis points, while increasing the allowance for credit losses to non-performing loans ratio by 109 percentage points.
INTS
Intensity Therapeutics, Inc. reported third-quarter 2026 financial results, showing a rise in research and development expenses to $2.4 million from $1.6 million in 2025, driven by increased costs from resuming patient enrollment in the Phase 3 INVINCIBLE-3 Study. The company also restarted patient enrollment in the Phase 2 INVINCIBLE-4 Study, with preliminary data indicating a 71% pathological complete response in patients receiving INT230-6. Additionally, Intensity Therapeutics raised $1.5 million under an at-the-market facility in the third quarter, bringing total proceeds to $3.2 million for the nine months ended September 30, 2026, with cash and cash equivalents standing at $8.5 million as of that date.
PH
Parker Hannifin Corporation reported record first quarter results for fiscal 2027, with sales increasing 18% to $6.0 billion and net income reaching $0.9 billion, a 9% increase. The company completed the acquisition of Filtration Group Corporation, expanding its filtration and aftermarket business. Adjusted EPS grew 10% to $6.92, with a record $8.90, and the company raised its full-year guidance for organic sales growth, adjusted segment operating margin, adjusted EPS, and free cash flow.
ACMR
ACM Research, Inc. reported third-quarter 2026 results, with revenue increasing 36.6% year-over-year to $367.7 million and shipments growing 30.6% to $343.5 million. The company's gross margin remained stable at 41.6%, while income from operations rose to $66.2 million, and net income attributable to ACM Research, Inc. increased to $40.5 million. Notable developments include the shipment of the first 310x310 mm Ultra ECP panel-level horizontal electroplating production tool to a customer in Asia and the introduction of an enhanced Single-Wafer Hot SPM system with sulfuric acid recycling capability. ACM Research, Inc. raised its 2026 revenue outlook, now expecting revenue above the upper end of its prior range, reflecting continued strong customer demand and expectations for robust shipment growth in the fourth quarter.
LNTH
Lantheus Holdings, Inc. reported third quarter 2026 financial results with worldwide revenue of $389.9 million, a 1.5% increase from the previous year. GAAP fully diluted earnings per share were $0.33, down from $0.41, while adjusted fully diluted earnings per share rose to $1.68 from $1.27. The company received FDA approval for TAUKLARIFY and BRAVNETSA and announced a definitive merger agreement with Curium, valued at up to approximately $8.0 billion.
ENVX
Enovix Corporation announced a cost reduction plan and business updates, focusing on expanding operations in South Korea while reducing costs in the U.S., India, and Malaysia. The company is investing $19 million to double drone battery capacity at its TAA-compliant plant in Korea, responding to strong demand from U.S. and allied defense programs for non-Chinese batteries. Enovix expects continued growth in this sector throughout the decade, with a focus on streamlining efforts to manage costs effectively.
DYN
Dyne Therapeutics, Inc. reported third-quarter 2026 financial results, with cash, cash equivalents, and marketable securities totaling $1.134 billion as of September 30, 2026, expected to fund operations into the second quarter of 2028. The company announced preparations for the potential U.S. launch of z-rostudirsen for exon 51 Duchenne muscular dystrophy under priority review by the FDA, with a target action date of January 21, 2027, and an anticipated launch in Q1 2027. Additionally, Dyne presented one-year clinical data from the Phase 1/2 ACHIEVE trial of z-basivarsen for myotonic dystrophy type 1, showing functional improvement, and disclosed preclinical data supporting the development of four investigational therapies for Duchenne muscular dystrophy.
MTSI
MACOM Technology Solutions Holdings, Inc. reported robust financial results for the fiscal year ended October 2, 2026. In the fourth quarter, revenue surged 62.7% to $424.8 million, with net income reaching $139.4 million ($1.78 per diluted share). For the full fiscal year, revenue grew 37.3% to $1,327.6 million, and net income was $335.3 million ($4.31 per diluted share). Adjusted non-GAAP results showed a fourth-quarter adjusted net income of $163.3 million ($2.09 per diluted share) and a fiscal-year adjusted net income of $435.7 million ($5.60 per diluted share). Management highlighted a strong fiscal year 2026 performance.
ARW
Arrow Electronics, Inc. reported record quarterly revenue of $10.7 billion for its third quarter of 2026, marking a 39% year-over-year increase. The company exceeded guidance with diluted EPS of $6.17 and non-GAAP diluted EPS of $6.22, driven by strong performance in its Global Components and Global Enterprise Computing Solutions divisions. Global Components' sales surged 43% year-over-year, while Global Enterprise Computing Solutions saw a 29% increase in sales, reflecting Arrow's diversified business model and focus on higher-margin services.
CRON
Cronos Group Inc. reported record third-quarter 2026 net revenue of $63.5 million, a 73% year-over-year increase, driven by strong performance in Canada and Israel. The company's gross profit rose by $14.0 million, while adjusted gross margin remained stable at 50.9%. Despite a decrease in net income to $17.8 million, adjusted EBITDA improved by $11.4 million to $17.1 million, with record net revenue also achieved in Germany.
MIDDV
Middleby Corporation has promoted Steven P. Spittle to President and Chief Executive Officer, effective immediately, with a transition to succeed Timothy J. FitzGerald as CEO on April 1, 2027. FitzGerald will step down from his CEO role and the Board of Directors on March 31, 2027, receiving severance benefits and pro-rated accelerated vesting of restricted stock units. Earlier in 2026, Middleby completed a portfolio transformation, selling a 51% stake in its Residential Kitchen business and spinning off its Food Processing business as Midera, positioning itself as a pure-play commercial foodservice company.
CW
Curtiss-Wright Corporation reported a 10% increase in third-quarter 2026 sales to $953 million, with operating income rising 13% to $188 million, resulting in a 19.7% operating margin. The company raised its full-year outlook, projecting sales growth of 8% to 10%, operating income growth of 12% to 14%, and diluted EPS growth of $15.40 to $15.60. Free cash flow reached $157 million, with total share repurchases amounting to $352 million, reflecting strong demand in defense electronics and growth across aerospace and defense markets.
BIII-WT
Black Spade Acquisition III Co agreed to amend its Business Combination Agreement with Astrum Space Inc and Astrum Networks Pte. Ltd., facilitating a merger where Astrum will merge into Black Spade III, which will survive the merger. Following the merger, Astrum Singapore will become a wholly-owned subsidiary of the surviving entity. The amended agreement also provides for the listing of the merger-surviving company on either the New York Stock Exchange or Nasdaq, as mutually agreed by the parties.
TICAW
TIC Solutions, Inc. reported a 35% increase in third-quarter revenue to $639.6 million, driven by the inclusion of NV5 Global, Inc. following its acquisition. The company achieved a record combined Consulting & Engineering and Geospatial backlog of $1.29 billion, up 23% year-over-year, and reported an Adjusted EBITDA of $107.2 million, a 39% increase. Despite a net loss of $11.1 million, TIC Solutions raised its full-year revenue outlook to $2,240 to $2,270 million and narrowed its Adjusted EBITDA guidance to $342 to $350 million, maintaining total liquidity of $293.3 million.
DFH
Dream Finders Homes, Inc. announced the early participation results of its private exchange offers for Beazer Homes USA, Inc.'s 7.500% Senior Notes due 2031 and 8.000% Senior Notes due 2032. As of November 4, 2026, eligible holders had tendered 99.22% of the 7.500% notes and 98.28% of the 8.000% notes. The settlement date for the exchange is expected to be November 23, 2026, with the proposed amendments eliminating restrictive covenants and events of default, becoming operative on that date.
TRIP
Tripadvisor, Inc. completed the sale of its online restaurant reservation and management platform, TheFork, to American Express Travel Related Services Company, Inc., for $700 million in an all-cash transaction on November 1, 2026. The transaction, subject to regulatory approvals and closing conditions, was finalized on the same day. As a result, TheFork is now classified as a discontinued operation, with Tripadvisor's financial statements reflecting this change retroactively to January 1, 2023.
COP
ConocoPhillips reported third-quarter 2026 earnings per share of $3.34 and adjusted earnings per share of $3.27, up from $1.38 and $1.61, respectively, in the same period of 2025. The company generated $7.2 billion in cash from operations, increased its quarterly dividend by 11% to $0.93 per share, and completed $2.4 billion in share repurchases. ConocoPhillips achieved record Permian completion efficiency and first production ahead of schedule at Surmont Pad 104W-B, while expanding its LNG offtake portfolio to 13 MTPA.
KRP
Kimbell Royalty Partners, LP reported record third-quarter 2026 results, achieving a daily production of 27,565 Boe/d, a 16% market share of land rigs in the U.S., and increased its borrowing base to $750 million. The company announced a 50% redemption of Series A Cumulative Convertible Preferred Units, reducing them to less than 3% of its $2.8 billion enterprise value. Kimbell declared a Q3 2026 cash distribution of $0.45 per common unit, reflecting a 75% payout ratio and a 10.7% annualized yield based on the October 30, 2026, closing price.
RGNX
Regenxbio Inc. secured compliance with a $38.0 million settlement agreement with Sarepta Therapeutics, resolving all patent litigation matters. The company reported third-quarter 2026 financial results, highlighting progress on its Duchenne muscular dystrophy gene therapy RGX-202, with a pre-Biologics License Application meeting expected with the FDA in Q4 2026 and potential approval in 2H 2027. Regenxbio's cash position as of September 30, 2026, was $251.0 million, up from $240.9 million as of December 31, 2025, primarily due to a $100.0 million milestone payment from AbbVie and net proceeds of $107 million.
WEN
The Wendy's Company reported unaudited financial results for the third quarter ended September 27, 2026, with net income of $15.1 million and adjusted EBITDA of $113.4 million. Global systemwide sales decreased 5.9% year-over-year, driven by a 7.6% decline in the U.S. and a 3.5% growth in international markets. The company initiated portfolio optimization actions, including planned acquisitions and signed a letter-of-intent to acquire up to 163 Wendy's restaurants from Meritage Hospitality Group, and announced the appointment of Tariq Hassan as Chief Marketing and Customer Growth Officer.
DTB
DTE Energy Company agreed to acquire all equity interests in DTE Energy Resources, LLC (d/b/a DTE Vantage) from Velocity BidCo LLC for approximately $2.97 billion, subject to adjustments. The transaction, unanimously approved by DTE's board on October 30, 2026, involves renewable energy projects and custom energy solutions, pending regulatory approvals and customary closing conditions. The deal is expected to close in mid-2027, with a termination fee of $148.5 million payable by Velocity BidCo LLC under specified circumstances.
CCLD
CareCloud, Inc. reported record financial results for the quarter ended September 30, 2026, with GAAP net income reaching $4.7 million, up 54% year over year, and GAAP EPS surging 150% to $0.10. Revenue increased 9% to $33.7 million, while adjusted EBITDA rose 28% to $9.9 million. The company repaid its Series B Preferred Stock for $41.6 million, reducing debt by $7.4 million, and reaffirmed its full-year revenue guidance for 2026, expecting between $128 million and $130 million.
BKV
BKV Corporation secured a Cost Reimbursement Agreement with a Leading Frontier AI Lab to expand modular power generation at the Temple Energy Complex from 200 MW to 400 MW, with a potential cap of $179 million. The company completed a $575 million Convertible Senior Notes Offering at an annual rate of 1.625%. BKV also received Verra carbon credit certification for CO2 sequestration, enabling monetization through its Carbon Sequestered Gas product. Additionally, the acquisition of assets in the Barnett Shale added approximately 65 MMcfe/d of production and 0.35 Tcfe of reserves.
CYCN
Korsana Biosciences, Inc. completed a merger with Cyclerion Therapeutics and secured a $380 million private placement in September 2026, bolstering its leadership and financial position. The biotech firm reported a third-quarter net loss of $46.4 million, with cash and cash equivalents totaling approximately $456.2 million as of September 30, 2026, expected to fund operations through 2029. Korsana anticipates releasing Phase 1 data for its Alzheimer's treatment candidate, KRSA-028, in mid-2027, with further proof-of-concept data by the end of 2027 or early 2028.
CORZR
Core Scientific, Inc. (NASDAQ: CORZ) reported a significant sequential increase in GAAP colocation revenue to $215.4 million for the third quarter ended September 30, 2026, driven by billing for 485 MW of capacity. Net income surged to $1.2 billion, aided by a non-cash gain in the change in fair value of warrants, while adjusted EBITDA more than tripled to $133.6 million, with margins expanding to 57%. Capital expenditures totaled $985.1 million, and liquidity and DSRA remained strong at $1,744.2 million.
MBUU
Malibu Boats, Inc. reported a 29.9% increase in net sales to $252.9 million for the quarter ended September 30, 2026, driven by the Saxdor acquisition and higher unit volumes in key segments. Gross profit rose 35.5% to $37.8 million, while GAAP net income improved to $6.1 million, supported by a 21.7% growth in adjusted EBITDA to $14.3 million. The company's strategic focus on aligning shipments with demand and launching new models underpins its financial performance and shareholder returns.
FATE
Fate Therapeutics, Inc. reported its third-quarter financial results, revealing $139.1 million in cash, cash equivalents, and investments, with a cash runway projected to mid-2028. The company announced a $15.0 million grant from the California Institute for Regenerative Medicine to support the RECLAIM-LN program. Additionally, preliminary Phase 1 data for RECLAIM-LN showed a 100% renal response, and early activation of clinical sites for the COMPLETE basket trial reflects strong interest in FT839, a novel dual CD19/CD38 targeting CAR T-cell product candidate.
BKSY-WT
BlackSky Technology Inc. reported record third-quarter 2026 results, with total revenue reaching $42.8 million, up 118% year-over-year, driven by Gen-3 services. The company posted a net income of $18.5 million and an adjusted EBITDA of $12.8 million, marking a 29.9% margin on revenue. BlackSky raised its full-year revenue outlook to $140-$150 million and adjusted EBITDA to $18-$24 million, while maintaining its capital expenditure outlook of $50-$60 million.
GLUE
Monte Rosa Therapeutics, Inc. reported robust financial results for the third quarter ended September 30, 2026, with a strong balance sheet featuring $582.6 million in cash, cash equivalents, restricted cash, and marketable securities. The company announced positive outcomes from the GFORCE-1 Phase 1 study of MRT-8102, achieving 80% to 90% NEK7 degradation, comparable to healthy volunteers, with adverse event rates similar to placebo. Monte Rosa has initiated Phase 2 studies for MRT-8102 in gout, coronary artery disease, and hidradenitis suppurativa, and Phase 2 studies for MRT-2359 in combination with apalutamide for metastatic castration-resistant prostate cancer, alongside Phase 2a/b studies of MRT-6160 in Sjögren's disease and psoriatic arthritis, with milestone payments expected.
ROK
Rockwell Automation reported fiscal 2026 fourth quarter and full-year results, with fourth quarter sales up 1% and organic sales up 3%, both reduced by 4 percentage points due to the customer tariff refund program. Diluted EPS rose 153% to $3.11, and Adjusted EPS increased 16% to $3.88, while full-year sales grew 8%, with diluted EPS up 63% to $12.54 and Adjusted EPS up 27% to $13.42. Cash provided by operating activities reached $1,958 million, and free cash flow was $1,701 million, both up 27% and 25% year over year, respectively, including a favorable $108 million impact from IEEPA tariff refunds and related interest income. Fiscal 2027 guidance includes reported sales growth of 4.5% to 7.5% and organic sales growth of 6% to 9%, with diluted EPS expected between $13.78 and $14.78 and Adjusted EPS between $14.50 and $15.50.
AMLX
Amylyx Pharmaceuticals, Inc. reported third-quarter 2026 financial results, highlighting positive topline results from the Phase 3 LUCIDITY clinical trial of avexitide in post-bariatric hypoglycemia (PBH), with a New Drug Application submission planned by year-end. The company strengthened its balance sheet through an upsized public offering, raising approximately $545 million in net proceeds, and increased its cash position to $768.1 million as of September 30, 2026. Research and development expenses rose to $28.4 million, driven by costs related to the LUCIDITY trial, while selling, general, and administrative expenses increased to $21.3 million.
U
Unity Technologies reported third quarter 2026 financial results, indicating strong performance with Vector revenue growing 126% year-over-year and 40% quarter-over-quarter, marking the first GAAP profitable quarter since the IPO. Strategic revenue reached $596.6 million, up 59% year-over-year, driven by growth in Strategic Grow and Strategic Create segments, while Non-Strategic revenue declined 73% to $25.5 million. Non-GAAP adjusted EBITDA improved to $257 million, up 132%-136% year-over-year, with adjusted EPS at $0.44, compared to $0.20 in the prior year quarter.
GNPX
Genprex, Inc. announced translational analysis results for its lead drug candidate, Reqorsa, a gene therapy product. The data indicate that increased TUSC2 expression is linked to a transcriptional shift toward cellular maintenance and resilience to aging-associated stress. These findings, presented at the Gerontological Society of America's 2026 Annual Scientific Meeting, were derived from whole-blood transcriptomes of 11 lung cancer patients in clinical trials, showing a biphasic response with initial immune activation followed by enhanced cellular maintenance.
MAIR
Madison Air Solutions Corporation reported a robust third quarter with a 119.3% year-over-year increase in backlog to $3,187.2 million and a 25.9% rise in orders. Net sales reached $1,126.7 million, up 25.4%, while net income surged 89.1% to $107.4 million, with an adjusted net income of $199.3 million, up 100.4%. The company anticipates completing the acquisition of ebm-papst soon after year-end, enhancing its market position.
KPTI
Karyopharm Therapeutics Inc. filed voluntary Chapter 11 bankruptcy petitions in the Southern District of Texas, Houston Division, on November 4, 2026. Nasdaq notified the company on November 2, 2026, that its securities would be delisted due to the bankruptcy filings and concerns about compliance with listing requirements. Trading of Karyopharm's common stock will be suspended on November 11, 2026, with potential over-the-counter trading under the symbol KPTIQ, though no assurance of commencement or maintenance of trading is provided.
ANIP
ANI Pharmaceuticals, Inc. reported third quarter 2026 financial results, showing revenue of $XX million and adjusted non-GAAP EBITDA of $XX million, marking a decrease from the same period in 2025. The company announced a proposed acquisition of Egetis Therapeutics, expected to close in the first quarter of 2027, subject to customary closing conditions. Additionally, ANI Pharmaceuticals appointed Stephen P. Carey as Chief Financial Officer, effective November 5, 2026. The company's stock continues to trade on the Nasdaq under the symbol "ANIP."
VIRT
Virtu Financial, Inc. announced its intention to reincorporate from Delaware to Texas under a Plan of Conversion, effective upon filing certificates with the Secretaries of State of both states. The conversion will maintain the company's existence, with each share of its common stock converting into a corresponding share of the Texas corporation. The Texas entity will assume all debts and liabilities, and the current directors, officers, and committees will continue in their roles. The Reincorporation Resolutions and the Plan of Conversion have been approved by the Board and TJMT Holdings LLC.
AGIO
Agios Pharmaceuticals reported a significant increase in worldwide net revenues for its mitapivat products, reaching $55.4 million in the third quarter of 2026, more than quadrupling from $12.9 million in the same period of 2025. The company extended the PDUFA goal date for its mitapivat sickle cell disease sNDA by three months to February 1, 2027, following the FDA's request for additional information. With $907.0 million in cash, cash equivalents, and marketable securities, Agios is fully funded for commercial launches and pipeline programs, targeting non-GAAP profitability in 2028.
EVMN
Evommune, Inc. announced a pre-recorded webcast on EVO570, a potential oral VAV1-directed molecular glue degrader, hosted by CEO Luis Peña and the management team. The webcast will discuss EVO570's preclinical profile, its development path in rheumatoid arthritis, and its role in Evommune's immunology pipeline. Evommune secured an exclusive license from Hinova Pharmaceuticals Inc., granting worldwide rights outside Greater China to develop, manufacture, and commercialize EVO570, aligning with its mission to address chronic inflammation.
SSMR
Sunshine Silver Mining & Refining Company completed a 50,000-meter infill drill program at the Sunshine Mine in Idaho's Silver Valley, reporting high-grade silver intercepts across multiple veins. The results, including a notable 7,069 gpt silver over 1.00 meter in the NY Boy Vein, support the Company's updated Mineral Resource Estimate expected in Q1 2027. These findings bolster the Sunshine Mine Feasibility Study, targeted for completion in Q2 2027, and a planned return to production in late 2028.
GHM
Graham Corporation reported its second quarter fiscal 2027 results, showing net sales of $69.8 million, a 6% increase driven by diversified revenue and the addition of FlackTek. Gross profit rose 38% to $19.7 million, with a gross profit margin of 28.2%, up 650 basis points due to improved mix and operational efficiencies. Net income per diluted share increased 39% to $0.39, while adjusted net income per diluted share rose 68% to $0.52, and adjusted EBITDA increased 64% to $10.3 million, with a margin of 14.8%, up 530 basis points. Orders totaled $73.7 million, with a book-to-bill ratio of 1.1x and a record backlog of $561.3 million, marking the seventh consecutive quarter of record quarterly backlog. The company reaffirmed its full-year fiscal 2027 guidance for net sales and adjusted EBITDA.
TCNNF
Trulieve Cannabis Corp. reported third-quarter 2026 results, achieving $230 million in revenue with a 64% gross margin and $148 million in gross profit. The company posted positive net income of $1 million and adjusted net income of $18 million, with adjusted EBITDA at $89 million, or 39% of revenue. Trulieve also completed a corporate domestication to Delaware, added to several stock indices, and opened two new dispensaries in Florida and Georgia.
TRGP
Targa Resources Corp. reported third quarter 2026 financial results, announcing adjusted EBITDA of $1.5 billion, an 18% year-over-year increase, and record Permian inlet, NGL transportation, and fractionation volumes. The company secured new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries for natural gas gathering and processing in the Permian Basin, and announced plans for three new natural gas processing plants. Targa expects full-year 2026 adjusted EBITDA to reach at least $6.0 billion, with net growth capital expenditures estimated at approximately $5.0 billion.
ENOV
Enovis Corporation reported a 2% growth in net sales to $559 million and a 5% increase in organic net sales to $591 million for the third quarter of 2026. The company announced a net income of $3 million, or 0.6% of sales, and adjusted EBITDA of $104 million, or 18.5% of sales. Enovis raised its full-year revenue guidance to $2.32-2.35 billion and adjusted EBITDA guidance to $428-438 million, while authorizing a new $200 million share repurchase program.
OSCR
Oscar Health, Inc. reported third-quarter 2026 financial results, showing total revenue of $5.1 billion, a 71% increase from the previous year, driven by rate increases and higher membership. The medical loss ratio improved to 84.0% from 88.5%, and the selling, general, and administrative expense ratio decreased to 14.0% from 17.5%. Earnings from operations turned positive at $178 million, reflecting strong operating performance, and adjusted EBITDA reached $206.9 million, up from a prior loss. The company raised its full-year 2026 outlook, projecting total revenue between $18.7 billion and $19.0 billion, earnings from operations between $600 million and $950 million, and adjusted EBITDA between $1.2 billion and $1.4 billion.
MFICL
MidCap Financial Investment Corporation reported a decline in net investment income per share to $0.34 for the quarter ended September 30, 2026, down from $0.40 in the same period in 2025, and a net asset value per share decrease to $12.86, a 3.8% drop from $13.37 as of June 30, 2026. The decline was primarily due to credit-related losses in a few portfolio positions, partially offset by net investment income exceeding dividends. The company made new investment commitments of $0.9 million and saw net repayments of $189 million, including a $28 million repayment from Merx Aviation Finance, LLC. Additionally, Ares Capital Corporation announced its agreement to acquire MFIC on October 27, 2026.
GCT
GigaCloud Technology Inc. reported record quarterly revenue of $423.6 million, a 27.4% year-over-year increase, and net income of $131.1 million, up 32.6% year-over-year, for the third quarter ended September 30, 2026. The company's diluted earnings per share rose 42.4% year-over-year to $1.41 for the quarter, while adjusted EBITDA increased 42.4% to $61.8 million. GigaCloud's Marketplace GMV grew 24.0% year-over-year to $1,846.2 million, with third-party seller GMV up 30.6% to $1,032.2 million. The company anticipates fourth-quarter 2026 revenues between $425 million and $450 million and announced a new $120 million share repurchase program effective August 6, 2026.
BEIGF
BeOne Medicines Ltd. reported a 34% increase in total global revenues to $1.9 billion for the third quarter of 2026, driven by BRUKINSA and TEVIMBRA sales. The company raised its 2026 revenue guidance to $6.9 to $7.0 billion, with gross margins reaching 88% on a GAAP basis and 88% on an adjusted basis. Net income and adjusted net income rose significantly, with basic and diluted earnings per share improving to $3.38 and $4.74 per ADS, respectively.
CGTX
Cognition Therapeutics, Inc. (CGTX) reported a third-quarter net loss of $4.1 million, or $(0.04) per share, compared to $4.9 million, or $(0.06) per share, in the same period of 2025. Research and development expenses rose to $5.1 million due to increased trial activities, while general and administrative expenses fell to $2.3 million. As of September 30, 2026, CGTX held approximately $31.5 million in cash and equivalents, with $18.2 million in obligated grant funds from the National Institute of Aging.
CELH
Celsius Holdings, Inc. reported third-quarter 2026 financial results, with revenue increasing 16.8% to $847.2 million, driven by a 28% contribution to the zero-sugar U.S. energy category's growth. North America revenue grew 15% to $806.2 million, while international revenue surged 78% to $41.0 million. Despite a gross margin decrease to 46.8% due to inflation and higher DSD sales, net income improved to $127.0 million from a prior-year loss of $(61.0) million.
IEP
Icahn Enterprises L.P. disclosed updated investor materials and non-GAAP financial measures in an 8-K filing on November 5, 2026. The report includes forward-looking statements on future performance, strategies, and risks across business segments like Energy and Real Estate. The company highlights potential impacts from economic downturns and regulatory inquiries, with further details available in its SEC filings.
LNC-PD
Lincoln reported a 21% sequential increase in annuities sales, totaling $4.3 billion, with spread-based products comprising 67% of sales. Life Insurance core sales grew by 3%, driven by a 36% increase in IUL growth, while Group Protection premiums rose by 3% year-over-year. Annuities earnings reached $304 million, up 6% sequentially but down 4% year-over-year, with Life Insurance earnings increasing by $76 million year-over-year. Group Protection earnings decreased by $33 million year-over-year. Lincoln resumed share repurchases, retiring over 40% of preferred stock, reducing financing costs, and increasing liquidity to approximately $1.0 billion, with a leverage ratio nearing the long-term target of 25%.
FA
First Advantage Corporation reported third quarter 2026 results, showcasing revenues of $465.8 million, a 12.8% year-over-year growth, and net income of $20.5 million. The company raised its full-year 2026 guidance to revenues of $1.720 billion to $1.745 billion and adjusted EBITDA of $488 million to $498 million. Additionally, First Advantage announced the acquisition of Data Diver Technologies, LLC, a data platform leveraging AI and automation, reflecting strong performance and confidence in delivering consistent profitable growth.
ECVT
Ecovyst Inc. reported a 51% increase in third-quarter 2026 sales to $308.6 million, driven by higher sales volume and pricing, including the impact of the Calabrian business acquisition. Adjusted EBITDA reached $61.2 million, up 6% from the prior year, while cash flow from operating activities was $80.7 million for the nine months ended September 30, 2026. The company raised its 2026 financial outlook, projecting Adjusted EBITDA between $208 million and $212 million, with Adjusted Net Income between $70 million and $85 million, reflecting strong momentum and capital allocation priorities.
GIL
Gildan Activewear reported third-quarter 2026 net sales from continuing operations of $1.47 billion, a 61.1% increase over the prior year, driven by the HanesBrands acquisition. The company's adjusted operating margin improved to 27.0%, exceeding guidance, and updated full-year revenue expectations to $5.4 billion to $5.5 billion. Gildan completed the sale of HanesBrands Australia and approved a share repurchase plan, with integration initiatives on track to realize $250 million in annual cost synergies by 2028.
ISOU
IsoEnergy Ltd. announced significant uranium discoveries during its 2026 summer exploration drilling at the Larocque East project in Canada's eastern Athabasca Basin. The company reported high-grade uranium intersections, including up to 15.4% U3O8 over 0.5 m, 500 m east of the Deposit on the L fault zone. These findings confirm previous spectrometer results and highlight the project's potential for efficient exploration and development due to its shallow mineralization and excellent infrastructure.
MRX
Marex Group Limited reported a robust third quarter 2026 performance, with revenue surging 53% to $743.2 million and Adjusted Profit Before Tax 1 climbing 75% to $176.1 million. The company's Clearing business and Prime revenue saw significant growth, with Prime revenue doubling to $115 million. Strategic acquisitions, including Bright Point, bolstered Clearing in Asia, while FX Market Making revenue more than tripled to $151 million, reflecting successful integration and market expansion.
NVMI
Nova Ltd. reported record quarterly revenue of $287.8 million, a 13% increase quarter-over-quarter and a 28% increase year-over-year for the third quarter ended September 30, 2026. The company also announced a fourth quarter financial outlook, expecting revenue between $305 million and $315 million, with diluted GAAP EPS between $2.78 and $2.93, and diluted non-GAAP EPS between $3.03 and $3.18 for the period ending December 31, 2026. Management highlighted strong performance in memory and advanced packaging solutions, driven by capacity expansions and robust demand for metrology solutions in memory devices.
HBCYF
HSBC Holdings plc has elected to redeem its US$2,250 million 7.390% Fixed Rate/Floating Rate Senior Unsecured Notes due 2028 in full on 9 November 2026 for a Make-Whole Redemption Amount of US$1,023.55 per US$1,000 principal. The redemption includes all accrued but unpaid interest up to the Redemption Date. Investors should surrender the securities at HSBC Bank USA's registered office in New York for processing.
ACB
Aurora Cannabis Inc. issued its interim financial report for the period ending September 30, 2026, revealing total assets of CAD 615.1 million. The company's liabilities include current liabilities of CAD 76.6 million, lease liabilities of CAD 15.3 million, and derivative liabilities of CAD 4.4 million. Aurora Cannabis disclosed material weaknesses in its internal control over financial reporting, which it is actively addressing, alongside changes that could materially affect its financial reporting controls.
NCSYF
NiCE (NASDAQ: NICE) has been recognized as a Leader in the IDC MarketScape: Worldwide Agentic Contact Center-as-a-Service Platforms 2026 Vendor Assessment. The company is celebrated for its unified CX AI platform, which integrates CXone and NiCE Cognigy to manage interactions across AI and human agents, as well as enterprise workflows. NiCE's leadership is further affirmed by its position in the 2026 Gartner Magic Quadrant for Contact Center as a Service, highlighting its vision in combining AI and human agents to enhance customer service outcomes.
CRNT
Ceragon Networks reported a third-quarter 2026 revenue increase of 11.7% year-over-year to $95.5 million, driven by growth in India and an improved revenue mix, resulting in a gross margin of 36.0%. The company generated $14.1 million in positive cash flow from operations and reported GAAP net income of $2.4 million, or $0.03 per diluted share, with non-GAAP net income of $6.2 million, or $0.07 per diluted share. Ceragon updated its 2026 outlook, projecting revenue between $365 million and $375 million, with non-GAAP gross margin expected to be between 33.5% and 34.5% and non-GAAP operating margin between 5% and 6%.
BPPFF
BP has successfully sold 5% of its stake in Aker BP, raising approximately $1.06 billion. Following the transaction, BP retains a 10.9% interest in Aker BP, holding 68.7 million shares. The proceeds will bolster BP's balance sheet, with full-year 2026 divestment proceeds now expected to reach around $9 billion, $1 billion above prior guidance. A 90-day lock-up applies to BP's remaining shares, subject to exemptions.
NMKBP
National Grid plc reported a statutory operating profit of £2,359 million for the half-year ended 30 September 2026, marking a 55% increase from the previous year, driven by a record £6.7 billion capital investment. Underlying operating profit rose to £2,591 million, up 13%, reflecting the impact of the new RIIO-T3 price control and growth in the US rate base. The company announced a $1.75 billion investment in Joulent to develop contracted power solutions for US large-load customers.
CDLR
Cadeler A/S completed a voluntary share exchange offer, known as the "Offer," to exchange its outstanding shares for one Cadeler Share, facilitating the redomiciliation of its parent company from Denmark to the United Kingdom. Following the Offer, shareholders who tendered their shares saw their relative shareholding in Cadeler increase by 8.62%, as approximately 7.94% of shareholders did not participate. Cadeler intends to initiate a compulsory acquisition of the remaining shares for cash, with a consideration of NOK 58.42 per share, within a four-week period starting from a notice expected on November 9, 2026.
HMDCF
HutchMed (China) Limited has secured Orphan Drug Designation from the US FDA for sovleplenib, targeting autoimmune hemolytic anemia (AIHA), marking its second designation following approval for primary immune thrombocytopenia (ITP). This designation grants 7 years of US market exclusivity upon approval, along with tax credits, user fee waivers, and specialized FDA guidance. Sovleplenib, a selective spleen tyrosine kinase inhibitor, is under review by China's NMPA, supported by positive trial data.
RDY
Dr. Reddy's Laboratories Ltd. received marketing authorization from Brazil's National Health Surveillance Agency (ANVISA) for its generic semaglutide injection, aimed at treating adults with type 2 diabetes. This approval enhances Dr. Reddy's footprint in Brazil, a significant market in Latin America with an estimated semaglutide market value of USD 244.6 million. The product will be available as a pre-filled, multi-dose injectable pen for once-weekly dosing.
CMCL
Caledonia Mining Corporation Plc secured a US$150 million interim financing facility to enhance financial flexibility for the Bilboes Gold Project in Zimbabwe. The facility, arranged by Stanbic Bank Zimbabwe Limited and CBZ Bank Limited, includes a revolving credit facility of up to US$50 million and a term facility of up to US$100 million, with an accordion option for an additional US$50 million. This financing underscores strong local banking sector support for the project's development.
Pre-Market Options Data
